Session 2: Emerging and Re-Emerging Diseases – 3rd James Hakim Memorial Lectures
Chaired by: Catherine Hankins and Clement Ahoussinou
11:10 AM – Emerging and Re-Emerging Diseases – Breaking the Cycle – (Ebola, Lassa, Yellow Fever, Marburg, Dengue, Mpox)
Ifedayo Adetifa, MBBS, FWACP (Paediatrics), MSc, PhD
Nigeria Centre for Disease Control & Prevention, Nigeria
11:30 AM – HIV-2
Didier Koumavi Ekouevi, MD, PhD
University of Lomé, Togo
11:50 AM – Audience Q&A
12:05 AM – Oral Abstract presentations I
Chaired by: Josue Avakoudjo & Samiratou Ouedraogo
12:05 PM – Inability-To-Walk-Unaided – A Single WHO Danger Sign Predicts In-Hospital Mortality in People Living With HIV in a Low-Resource Setting
#1 – Chikaiko Malunda, Malawi
12:15 PM – Eligibility for Long-Acting Cabotegravir/Rilpivirine and Archived Drug Resistance Mutations Among People Living with HIV-1 subtype C in Botswana
#2 – Dorcas Maruapula, Botswana
12:25 PM Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs for Combination With the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- And Middle-Income Countries
#3 – Alex Durand Nka, Cameroon
12:35 PM – Transition to 3-Test HIV Testing Algorithm Saves 371 Individuals From Potential Misdiagnosis: Lessons From Malawi’s HIV Testing Program
#4 – Tiwonge Chirwa, Malawi